C-Mune Therapeutics is a Hyderabad-based biopharmaceutical company dedicated to advancing healthcare through innovation in biologic drug research and development. Established in March 2024, we specialize in creating groundbreaking solutions like vaccines for multidrug-resistant infections, novel immunotherapies for autoimmune diseases, and sophisticated biosimilars.
With a strong foundation in scientific expertise, ethical practices, and a vision for making life-saving therapies affordable and accessible, we are committed to addressing some of the most critical challenges in global healthcare. Combining systems biology, artificial intelligence, and cutting-edge technology, C-Mune Therapeutics is poised to shape the future of biopharma and improve patient outcomes worldwide.
